Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....
Vous n'êtes pas connecté
- English
- Français
- عربي
- Español
- Deutsch
- Português
- русский язык
- Català
- Italiano
- Nederlands, Vlaams
- Norsk
- فارسی
- বাংলা
- اردو
- Azərbaycan dili
- Bahasa Indonesia
- Հայերեն
- Ελληνικά
- Bosanski jezik
- українська мова
- Íslenska
- Türkmen, Түркмен
- Türkçe
- Shqip
- Eesti keel
- magyar
- Қазақ тілі
- Kalaallisut ; kalaallit oqaasii
- Lietuvių kalba
- Latviešu valoda
- македонски јазик
- Монгол
- Bahasa Melayu ; بهاس ملايو
- ဗမာစာ
- Slovenščina
- тоҷикӣ ; toğikī ; تاجیکی
- ไทย
- O'zbek ; Ўзбек ; أۇزبېك
- Tiếng Việt
- ភាសាខ្មែរ
- རྫོང་ཁ
- Soomaaliga ; af Soomaali
Maroc - MOUNTAINTODAY.IN - A La Une - 11/Jul 18:28
Osteoarthritis Pipeline 2024 | Biosplice Therapeutics, Gilead Sciences, Flexion Therapeutics, GlaxoSmithKline, Levicept, Arthrogen, Personalized Stem Cells, Peptinov, Asahi Kasei Pharma
DelveInsight’s, “Osteoarthritis Pipeline Insight 2024” report provides comprehensive insights about 130+ companies and 130+ pipeline drugs in the Osteoarthritis pipeline landscape. It covers the Osteoarthritis pipeline drug profiles, including Osteoarthritis clinical and nonclinical stage products. It
Articles similaires
Interstitial Cystitis Market Report 2032: Epidemiology Data, Pipeline Therapies, Latest EMA, PDMA, FDA Approvals by DelveInsight | Merck & Co, Teva Pharmaceutical Industries, Integrative Therapeutics
mountaintoday.in - 04/Sep 07:57
Interstitial Cystitis market The Interstitial Cystitis market size is anticipated to grow with a significant CAGR during the study period (2019-2032)....
Collegium Pharma acquires Ironshore Therapeutics
pharmabiz.com - 06/Sep 00:00
Collegium Pharmaceutical Inc, a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious...
TRODELVY (sacituzumab govitecan) powder, for solution [Gilead Sciences]
nlm.nih.gov - 06/Sep 04:00
Updated Date: Fri, 06 Sep 2024 00:00:00 EDT
Gilead Sciences (GILD) Stock Sinks As Market Gains: What You Should Know
zacks.com - 21:50
Gilead Sciences (GILD) reachead $81.01 at the closing of the latest trading day, reflecting a -0.53% change compared to its last close.
Novel microscopy technique reveals the mechanics of mitotic chromosome condensation
news.medical.net - 29/Aug 04:31
A team of scientists studying cell division developed a special light microscopy system and used it to analyze the molecular density of cellular...
World-first stem cell breakthrough for bone marrow
thewest.com.au - 02/Sep 17:31
Australian scientists have created lab-grown blood stem cells that survive in animals, sparking hopes of better medical treatments.
World-first stem cell breakthrough for bone marrow
thewest.com.au - 02/Sep 17:31
Australian scientists have created lab-grown blood stem cells that survive in animals, sparking hopes of better medical treatments.
Researchers discover blood stem cell could transform bone marrow transplants
hindustantimes.com - 03/Sep 04:52
The study has successfully surmounted a significant obstacle in the production of human blood stem cells.
Iron Deficiency Anemia Market Analysis 2034 | Iron Deficiency Anemia Therapies, Clinical trials, Iron Deficiency Anemia prevalence, Treatment Algorithms | Akebia Therapeutics, Shield Therapeutics
mountaintoday.in - 04/Sep 08:17
Iron Deficiency Anemia Market As per DelveInsight, the Iron Deficiency Anemia Market is anticipated to grow immensely in the coming years owing to the...
Les derniers communiqués
-
Aucun élément